d-alpha tocopherol has been researched along with Narcolepsy in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, N; Gringras, P; Miller, E; Quinnell, T; Shneerson, J; Stowe, J; Zaiwalla, Z | 1 |
| Bauchau, V; Bekkat-Berkani, R; Cohet, C; Doherty, TM; Garçon, N; Innis, BL; Rappuoli, R; Schuind, A; Tavares Da Silva, F; van der Most, R | 1 |
| Bruun Laursen, A | 1 |
| Ahmed, SS; MacDonald, NE; Schur, PH; Steinman, L | 1 |
| Hildt, E; Kunz, K; Masoudi, S; Ploen, D | 1 |
| De Wals, P; Deceuninck, G; Desautels, A; Mignot, E; Montplaisir, J; Ouakki, M; Petit, D; Quinn, MJ | 1 |
2 review(s) available for d-alpha tocopherol and Narcolepsy
| Article | Year |
|---|---|
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
Topics: Adjuvants, Immunologic; alpha-Tocopherol; Animals; Antibodies, Viral; Clinical Trials as Topic; Drug Combinations; Hemagglutination Inhibition Tests; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Narcolepsy; Pharmacovigilance; Polysorbates; Squalene; Vaccination; Vaccines, Inactivated | 2019 |
Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
Topics: Adjuvants, Immunologic; alpha-Tocopherol; Antibodies, Viral; Antigens, Viral; Autoimmunity; Canada; Drug Combinations; Europe; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Narcolepsy; Pandemics; Polysorbates; Squalene; Vaccination | 2014 |
5 other study(ies) available for d-alpha tocopherol and Narcolepsy
| Article | Year |
|---|---|
Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
Topics: Adolescent; alpha-Tocopherol; Child; Child, Preschool; Drug Combinations; England; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Narcolepsy; Odds Ratio; Pandemics; Polysorbates; Risk Factors; Squalene; Surveys and Questionnaires; Vaccination | 2020 |
Autoimmune diseases and vaccines.
Topics: Adjuvants, Immunologic; alpha-Tocopherol; Autoimmune Diseases; Drug Combinations; Guillain-Barre Syndrome; Humans; Influenza Vaccines; Influenza, Human; Meningococcal Infections; Meningococcal Vaccines; Narcolepsy; Papillomavirus Infections; Papillomavirus Vaccines; Polysorbates; Squalene | 2016 |
[Catastrophic consequences of Pandemrix swine flu vaccine containing squalene].
Topics: Adjuvants, Immunologic; alpha-Tocopherol; Drug Combinations; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Narcolepsy; Polysorbates; Squalene | 2013 |
The adjuvant component α-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy.
Topics: Adjuvants, Immunologic; alpha-Tocopherol; Animals; Cell Line, Tumor; HLA-DQ beta-Chains; Humans; Intracellular Signaling Peptides and Proteins; Mice; Narcolepsy; Neurons; Neuropeptides; NF-E2-Related Factor 2; NF-kappa B; Orexins; Promoter Regions, Genetic; Proteasome Endopeptidase Complex | 2014 |
Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.
Topics: Adjuvants, Immunologic; Adolescent; Adult; alpha-Tocopherol; Case-Control Studies; Child; Drug Combinations; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Narcolepsy; Polysorbates; Quebec; Retrospective Studies; Squalene; Vaccination; Young Adult | 2014 |